Phase 3 transitional cell carcinoma Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Stage IV Ovarian Cancer AJCC v8Stage IIIC Ovarian Cancer AJCC v8Advanced Ovarian Carcinoma+22 more

M.D. Anderson Cancer Center580 enrolled19 locationsNCT04575935

Completed

Phase 3

Intravesical instillation therapy for high-risk non-muscle-invasive transitional cell carcinoma of the bladder: Does the strain of Bacillus Calmette-Guerin (BCG) matter?

Non-muscle-invasive transitional cell carcinoma of the bladder

Department of Urology, Inselspital Bern149 enrolled1 locationACTRN12611000204943

Completed

Phase 3

Efficacy study of adding chemotherapy to radiotherapy for treating bladder cancer

Transitional Cell Carcinoma of Urinary bladder

Kumar Gogna150 enrolled1 locationACTRN12607000041459